Oncocyte To Present New Data at 2021 American Association for Cancer Research (AACR) Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
March 15, 2021 08:00 ET
|
Oncocyte Corporation
-Results achieved in metastatic bladder cancer suggests Oncocyte’s DetermaIO test may be a strong predictor of Immune Checkpoint Inhibitor (ICI) therapy response in a third cancer type in addition to...
Oncocyte Announces Formation of Medical Advisory Board
March 09, 2021 08:00 ET
|
Oncocyte Corporation
IRVINE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NASDAQ: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across...
Oncocyte Announces Agreement with MultiPlan Network, Expanding Patient Access to DetermaRx™
March 04, 2021 08:00 ET
|
Oncocyte Corporation
IRVINE, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points...
Oncocyte to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16
March 03, 2021 16:01 ET
|
Oncocyte Corporation
IRVINE, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points...
Oncocyte Closes Second Investment In Razor Genomics to Complete Acquisition
February 25, 2021 08:00 ET
|
Oncocyte Corporation
IRVINE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points...
Oncocyte to Begin Trading on the Nasdaq Stock Market on March 8, 2021
February 23, 2021 16:05 ET
|
Oncocyte Corporation
IRVINE, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points...
Oncocyte to Participate in Fireside Chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 16, 2021 16:05 ET
|
Oncocyte Corporation
IRVINE, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points...
Oncocyte Announces Closing of $40 Million Public Offering of Common Stock
February 09, 2021 16:05 ET
|
Oncocyte Corporation
IRVINE, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points...
Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock
February 05, 2021 08:25 ET
|
Oncocyte Corporation
IRVINE, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points...
Oncocyte Announces Proposed Public Offering of Common Stock
February 04, 2021 16:05 ET
|
Oncocyte Corporation
IRVINE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points...